- Corporate Officers - H
- Hasnain Faheem
Insider Trading History of Hasnain Faheem
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hasnain Faheem since 2006.
This trader's CIK number is 1352620.
At the time of last reporting, Hasnain Faheem was the Officer of Kura Oncology, Inc.. (stock ticker symbol KURA).
Also see all insider trading activities at Kura Oncology, Inc..
Note that in the past
Hasnain Faheem also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Gossamer Bio, Inc. (GOSS) by Hasnain Faheem
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2024 | GOSS | 372,000 | $250,356 | 23,172 | $26,763 | 0 | $0 |
2023 | GOSS | 878,572 | $1,000,367 | 0 | $0 | 0 | $0 |
2022 | GOSS | 138,696 | $999,998 | 19,035 | $169,697 | 0 | $0 |
2020 | GOSS | 96,520 | $1,000,043 | 0 | $0 | 0 | $0 |
2019 | GOSS | 10,000 | $167,979 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Biogen Inc. (BIIB) by Hasnain Faheem
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2008 | BIIB | 0 | $0 | 43,262 | $2,703,017 | 35,642 | $1,411,435 |
2007 | BIIB | 0 | $0 | 7,446 | $364,854 | 5,467 | $0 |
2006 | BIIB | 0 | $0 | 11,244 | $501,617 | 0 | $0 |
Yearly summary of insider trading at Mirati Therapeutics, Inc. (MRTX) by Hasnain Faheem
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2023 | MRTX | 10,791 | $299,989 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Nuvation Bio Inc. (NUVB) by Hasnain Faheem
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2021 | NUVB | 0 | $0 | 0 | $0 | 25,000 | $0 |
Yearly summary of insider trading at Kura Oncology, Inc. (KURA) by Hasnain Faheem
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | KURA | 0 | $0 | 22,682 | $181,456 | 22,682 | $143,350 |
Yearly summary of insider trading at Immunic, Inc. (VTL) by Hasnain Faheem
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2018 | VTL | 0 | $0 | 177,443 | $77,720 | 0 | $0 |
2017 | VTL | 59,200 | $247,870 | 0 | $0 | 0 | $0 |
2016 | VTL | 118,243 | $699,998 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Receptos, Inc. (RCPT) by Hasnain Faheem
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2014 | RCPT | 0 | $0 | 200,000 | $21,893,755 | 0 | $0 |
Yearly summary of insider trading at Forte Biosciences, Inc. (TOCA) by Hasnain Faheem
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | TOCA | 43,000 | $215,559 | 0 | $0 | 0 | $0 |
2017 | TOCA | 100,000 | $1,000,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 8 companies by Hasnain Faheem:
1. Gossamer Bio, Inc. (GOSS)
2. Biogen Inc. (BIIB)
3. Mirati Therapeutics, Inc. (MRTX)
4. Nuvation Bio Inc. (NUVB)
5. Kura Oncology, Inc. (KURA)
6. Immunic, Inc. (VTL)
7. Receptos, Inc. (RCPT)
8. Forte Biosciences, Inc. (TOCA)
Table 1. Insider trading of Gossamer Bio, Inc. (GOSS) by Hasnain Faheem
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2024-06-21 | GOSS | Buy | 372,000 | .67 | 250,356 |
2024-03-27 | GOSS | Sale | 23,172 | 1.16 | 26,763 |
2023-03-22 | GOSS | Buy | 440,500 | 1.14 | 503,491 |
2023-03-21 | GOSS | Buy | 269,389 | 1.20 | 322,458 |
2023-03-20 | GOSS | Buy | 168,683 | 1.03 | 174,418 |
2022-07-15 | GOSS | Buy | 138,696 | 7.21 | 999,998 |
2022-03-23 | GOSS | Sale | 19,035 | 8.91 | 169,697 |
2020-10-14 | GOSS | Buy | 96,520 | 10.36 | 1,000,043 |
2019-09-27 | GOSS | Buy | 10,000 | 16.80 | 167,979 |
Table 2. Insider trading of Biogen Inc. (BIIB) by Hasnain Faheem
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2008-07-09 | BIIB | Option Ex | 30,175 | 46.77 | 1,411,435 |
2008-07-09 | BIIB | Sale | 36,837 | 62.13 | 2,288,830 |
2008-04-08 | BIIB | Sale | 6,425 | 64.47 | 414,187 |
2008-02-06 | BIIB | Option Ex | 5,467 | .00 | 0 |
2007-05-23 | BIIB | Sale | 7,446 | 49.00 | 364,854 |
2007-02-06 | BIIB | Option Ex | 5,467 | .00 | 0 |
2006-10-02 | BIIB | Sale | 11,244 | 44.61 | 501,617 |
Table 3. Insider trading of Mirati Therapeutics, Inc. (MRTX) by Hasnain Faheem
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2023-08-11 | MRTX | Buy | 10,791 | 27.80 | 299,989 |
Table 4. Insider trading of Nuvation Bio Inc. (NUVB) by Hasnain Faheem
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2021-02-10 | NUVB | Option Ex | 25,000 | .00 | 0 |
Table 5. Insider trading of Kura Oncology, Inc. (KURA) by Hasnain Faheem
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-03-21 | KURA | Option Ex | 22,682 | 6.32 | 143,350 |
2025-03-21 | KURA | Sale | 22,682 | 8.00 | 181,456 |
Table 6. Insider trading of Immunic, Inc. (VTL) by Hasnain Faheem
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2018-09-13 | VTL | Sale | 177,443 | .44 | 77,720 |
2017-09-14 | VTL | Buy | 59,200 | 4.19 | 247,870 |
2016-08-12 | VTL | Buy | 118,243 | 5.92 | 699,998 |
Table 7. Insider trading of Receptos, Inc. (RCPT) by Hasnain Faheem
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2014-11-10 | RCPT | Sale | 136,795 | 109.69 | 15,005,043 |
2014-11-11 | RCPT | Sale | 63,205 | 108.99 | 6,888,712 |
Table 8. Insider trading of Forte Biosciences, Inc. (TOCA) by Hasnain Faheem
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-05-30 | TOCA | Buy | 43,000 | 5.01 | 215,559 |
2017-04-19 | TOCA | Buy | 100,000 | 10.00 | 1,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Hasnain Faheem
(Officer of Kura Oncology, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.